Coppell Advisory Solutions’s ProShares Ultra Health Care RXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.95M Buy
+1,161
New +$54.4K 0.16% 115
2025
Q1
Sell
-1,156
Closed -$50.8K 1536
2024
Q4
$50.8K Hold
1,156
0.01% 579
2024
Q3
$63.9K Buy
1,156
+2
+0.2% +$109 0.01% 490
2024
Q2
$58.7K Buy
+1,154
New +$57.1K 0.01% 454
2023
Q4
$52.7K Hold
1,152
0.01% 486
2023
Q3
$54.4K Hold
1,152
0.02% 284
2023
Q2
$50.1K Buy
+1,152
New +$50.7K 0.01% 367
2023
Q1
Sell
-1,152
Closed -$54.4K 890
2022
Q4
$54.4K Buy
+1,152
New +$52.2K 0.02% 287

Other funds holding RXL

Coppell Advisory Solutions's RXL Position: Q2 2026 in Review

Coppell Advisory Solutions opened a new position in ProShares Ultra Health Care (RXL) in Q2 2026: 1,161 shares worth $1.95M. The stake represents 0.16% of the portfolio and ranks #115 among its holdings. This is a return to the name: Coppell Advisory Solutions previously reported a position in RXL as recently as Q4 2024.

Coppell Advisory Solutions first reported a position in RXL in Q4 2022 and has held it in 8 quarters since. 16 funds tracked by Wall St. Rank hold RXL as of Q2 2026.

  • Coppell Advisory Solutions held 1,161 shares of ProShares Ultra Health Care worth $1.95M as of Q2 2026.
  • ProShares Ultra Health Care was a new Coppell Advisory Solutions position in Q2 2026.
  • ProShares Ultra Health Care made up 0.16% of Coppell Advisory Solutions's portfolio in Q2 2026, its #115 holding.
  • Coppell Advisory Solutions first reported a position in ProShares Ultra Health Care in Q4 2022 and has held it in 8 quarters since.
  • 16 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q2 2026.

Based on Coppell Advisory Solutions's 13F filing for Q2 2026, filed 14 Aug 2026.